The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic
NCT05098600 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 123
Last updated 2024-12-03
Summary
The study series consists of three studies with the aim to assess the incidence, prevalence, risk factors, comorbidities and management of patients with alopecia areata in Czech Republic based on the patients and registry of a dermatology clinic of a metropolitan hospital.
Conditions
- Alopecia Areata
- Alopecia Totalis
- Alopecia Universalis
- Alopecia Areata (& Ophiasis)
- Alopecia Barbae
- Alopecia Diffuse
- Autoimmune Diseases
- Autoimmune Hyperthyroidism
- Autoimmune Hypothyroidism
- Diabetes Mellitus, Type 1
- Ulcerative Colitis
- Inflammatory Bowel Diseases
- Crohn Disease
- Rheumatoid Arthritis
- Down Syndrome
- Atopic Dermatitis
- Atopic Asthma
- Atopic Rhinitis
- Vitiligo
- Psoriasis
- Ankylosing Spondylitis
- Multiple Sclerosis
- Lupus Erythematosus
- COVID-19 Pandemic
- Vaccine Reaction
- Infections
- Anemia, Pernicious
Interventions
- OTHER
-
Exposure of interest
Common autoimmune and atopic conditions consist of atopic dermatitis, allergic rhinitis, asthma, Crohn's disease, ulcerative colitis, Celiac disease, Pernicious anaemia, Type 1 diabetes, Autoimmune thyroiditis (Hashimoto's thyroiditis, Grave's disease, atrophic, unspecified), rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, polymyalgia rheumatica, Systemic lupus erythematosus, Sjogren syndrome, psoriasis, vitiligo, Multiple sclerosis
Sponsors & Collaborators
-
Faculty Hospital Kralovske Vinohrady
lead OTHER_GOV
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-10-15
- Primary Completion
- 2022-10-14
- Completion
- 2022-12-20
Countries
- Czechia
Study Locations
More Related Trials
-
Long-Term PF-06651600 for the Treatment of Alopecia Areata
NCT04006457 ·Status: COMPLETED ·Phase: PHASE3
-
Healthcare Disparities in Alopecia Areata
NCT05727306 ·Status: COMPLETED
-
A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Alopecia Areata
NCT05556265 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata
NCT05398809 ·Status: RECRUITING ·Phase: PHASE2
-
Assessment of Biological and Biometrological Parameters in Adult Subjects with Androgenetic Alopecia
NCT06854432 ·Status: TERMINATED ·Phase: NA
-
Efficacy and Tolerability Study of Two Dosing Regimens of CTP-543 in Adults With Alopecia Areata
NCT03941548 ·Status: COMPLETED ·Phase: PHASE2
-
Alopecia Areata Registry
NCT00069589 ·Status: ACTIVE_NOT_RECRUITING
-
Effectiveness and Safety of Tofacitinib in Patients With Extensive and Recalcitrant Alopecia Areata
NCT03800979 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluate the Efficacy and Safety of SHR0302 in Adult Patients With Severe Alopecia Areata
NCT05470413 ·Status: UNKNOWN ·Phase: PHASE3
-
Study of EQ101 in Adult Subjects With Moderate to Severe Alopecia Areata
NCT05589610 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD)
NCT03359356 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Efficacy and Tolerability of Treatment With Interleukin-2 in Severe and Resistant Alopecia Areata
NCT01840046 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
A Phase II Study in Patients With Alopecia Areata
NCT04346316 ·Status: COMPLETED ·Phase: PHASE2
-
Alefacept in Patients With Severe Scalp Alopecia Areata
NCT00167102 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial to Evaluate Effectiveness of a Probiotic Preparation Administered to Patients With Alopecia Areata
NCT05599607 ·Status: COMPLETED ·Phase: NA
-
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata
NCT03898479 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
A Study of Secukinumab for the Treatment of Alopecia Areata
NCT02599129 ·Status: TERMINATED ·Phase: PHASE2
-
Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants
NCT02812342 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Serum Levels of Interlukin-15 and Interlukin-21 in Patients With Alopecia Areata
NCT05910138 ·Status: UNKNOWN ·Phase: NA
-
Safety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis (AT)
NCT03315689 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of LAD603 in Adults With Alopecia Areata
NCT07311564 ·Status: RECRUITING ·Phase: PHASE2
-
PF-06651600 for the Treatment of Alopecia Areata
NCT03732807 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
European Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata
NCT05041803 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata
NCT06826196 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry
NCT06562270 ·Status: RECRUITING